Announced
Completed
Synopsis
Lubea, a private investment firm, completed the acquisition of a 26% stake in Esteve, a pharmaceutical company. Financial terms were not disclosed. "We are thrilled to have Lubea on board as a strategic partner. This investment will provide us with the necessary resources to accelerate our growth and expand our presence in international markets, while remaining true to our purpose of improving people's lives through our innovative pharmaceutical products," Staffan Schüberg, ESTEVE CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.